RxSight, Inc.
$4.73
The Read: RXST has historically moved about 14%.5% on average to catalyst outcomes, including June 18 events, with sharp sell-offs driven by disappointing guidance or earnings misses but rare outsized rallies—up to 176.8%—when clinical data or competitive positioning exceeded expectations.
Price
Overlays
Panel
RXST
Hover to view data
No Data